Key Findings
Pharmaceutical formulation development has expanded in scope and complexity, ranging from the initial physicochemical characterization of novel molecules to the design of advanced modalities like lipid nanoparticle (LNP)-delivered messenger RNA (mRNA) vaccines. As of August 2026, formulation development continues to be one of the most impactful stages in the drug development pipeline. Specifically, a review of clinical trial data from 2010 to 2017 clearly indicates that 10% to 15% of development failures are directly attributable to poor ‘drug-like’ properties, including solubility, permeability, and pharmacokinetics.
Technical and Clinical Details
Formulation development aims to stabilize active pharmaceutical ingredients (APIs), optimize their absorption, distribution, metabolism, and excretion (ADME) profiles in vivo, and deliver them effectively to the intended target site. It has evolved from traditional dosage forms like tablets, capsules, and injectables to more complex modalities such as LNP-delivered mRNA vaccines, antibody-drug conjugates (ADCs), gene therapies, and cell therapies. LNPs are critical nanoparticle technologies essential for protecting water-soluble nucleic acid molecules and delivering them across cell membranes into the cytoplasm. However, if an API has insufficient physicochemical properties, desired therapeutic effects may not be achieved, even with innovative delivery systems. Low solubility hinders oral absorption, poor permeability limits cellular uptake, and unfavorable pharmacokinetics make it difficult to maintain desired blood concentrations. Identifying and overcoming these issues through formulation design at an early stage is critically important.
Background and Industry Context
The success rate of pharmaceutical development has historically been low, requiring vast amounts of time and cost. Even when new drug candidates advance to clinical trials, many fail due to issues of efficacy, safety, or pharmacokinetics. The rise of new modalities has further heightened the importance of formulation development. The success of LNP technology in COVID-19 vaccines demonstrated the potential for nanoparticle-mediated delivery systems to enable the clinical application of drugs previously considered impossible. However, this success also reconfirmed that LNPs themselves are not a perfect solution and that the underlying ‘drug-like’ properties of the API remain crucial. Formulators must work closely with chemists and biologists to consider manufacturability from the earliest stages of molecular design.
Strategic Significance and Outlook
The field of pharmaceutical formulation development will continue to be a hub of innovation. Further optimization of LNP technology, development of new nanoparticle delivery systems, and formulation design leveraging artificial intelligence (AI) and machine learning (ML) are predicted to accelerate. These technological advancements will expand the possibilities for effectively translating molecules with solubility or permeability challenges into clinical applications. Furthermore, with the advancement of personalized medicine, the development of customized formulations tailored to individual patient characteristics will become increasingly important. Strengthening formulation development will be key to improving the overall success rate and efficiency of drug development, bringing more innovative therapies to patients. This is expected to address unmet medical needs and significantly improve patient quality of life.
Source: https://intuitionlabs.ai/articles/pharmaceutical-formulation-development
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments